OTTAWA, ON — Today, BioTalent Canada announced the launch of a new program: the Skilled Newcomer Internships for the Bio-economy program that will provide employers with funds to integrate skilled… Read More
SKYRIZI® (risankizumab-rzaa) met the primary endpoint of ACR20 at week 24 in two pivotal studies, demonstrating significant improvement in joint symptoms, including swollen, tender and painful joints, compared to placebo[1,2,3]… Read More
Collaboration will enable transparent, cGMP, and scalable manufacture of custom cell culture media Cytiva, a global life sciences leader, and Nucleus Biologics, LLC, The Cell Performance Company™, have signed a… Read More
Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to… Read More
CBT is the first of several rare cannabinoid launches planned for the first half of 2022; includes CBDV and THCV Expands the Company’s rare cannabinoid product portfolio, which also includes… Read More
